Strata Skin SciencesFRA:E2O 38 Median PS Value is €105.62 as of Jun. 30, 2026, which is 100% below its 10-year median of 0.45. GuruFocus rates FRA:E2O with a GF Score™ of 38/100 and a GF Value™ of €58.84. The stock has 5 warning signs investors should review. Among 335 Medical Devices & Instruments companies, Strata Skin Sciences ranks better than 99.4% on this metric.
This valuation method assumes that the stock valuation will revert to its historical (10-Year) median in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.
The historical rank and industry rank for Strata Skin Sciences's Median PS Value or its related term are showing as below:
FRA:E2O'
s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.04 Med: 0.45 Max: 0.85
Current: 0.04
During the past 13 years, the highest Price to Median PS Value of Strata Skin Sciences was 0.85. The lowest was 0.04. And the median was 0.45.
FRA:E2O's Price-to-Median-PS-Value is ranked better than 99.4% of 335
companies
in the Medical Devices & Instruments industry
Industry Median: 0.71
vs FRA:E2O: 0.04
Strata Skin Sciences (FRA:E2O) Median PS Value Explanation
This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio
is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.
It also assumes that over time the profit margin is constant. If a company increases its profit margin to a sustainable level, this value might under-estimate its value. If it has permanent declined profit margins, this may over-estimate the company's value.
Strata Skin Sciences's Price to Median PS Value for today is calculated as
Price to Median PS Value
=
Share Price
/
Median PS Value
=
3.76
/
105.62
=
0.04
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Strata Skin Sciences Median PS Value Related Terms
Strata Skin Sciences Median PS Value Historical Data
* Premium members only.
The historical data trend for Strata Skin Sciences's Median PS Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:E2O vs ODYY, NUMD, PFSA: Median PS Value Comparison
For the Medical Devices subindustry, Strata Skin Sciences's Price-to-Median-PS-Value, along with its competitors' market caps and Price-to-Median-PS-Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Strata Skin Sciences Price-to-Median-PS-Value vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Strata Skin Sciences's Price-to-Median-PS-Value distribution charts can be found below:
* The bar in red indicates where Strata Skin Sciences's Price-to-Median-PS-Value falls into.
10-Year Median PS Ratio is 17.8171.
Strata Skin Sciences's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was €5.928.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Strata Skin Sciences (FRA:E2O) has a Median PS Value of €105.62 as of Jun. 30, 2026. Median price-sales value is the stock value based on a company's 10-year median price-sales ratio, View historical data on Strata Skin Sciences and its competitors. This is 23371% above median its historical median of 0.45. Over the past decade, Strata Skin Sciences' Median PS Value has ranged from 0.04 to 0.85. According to the industry distribution chart, Strata Skin Sciences ranks #2 out of 335 companies in the Medical Devices & Instruments industry, placing it in the top 0.59999999999999%.
Is Strata Skin Sciences' Median PS Value too high?
Strata Skin Sciences' current Median PS Value of €105.62 is 23371% above median its 10-year median of 0.45. Over the past 10 years, this metric has ranged from a low of 0.04 to a high of 0.85. Based on the distribution chart, Strata Skin Sciences ranks #2 out of 335 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Strata Skin Sciences has a GF Score™ of 38/100, reflecting its overall financial health beyond just this single metric.
How does Strata Skin Sciences' Median PS Value compare to ODYY and NUMD?
According to the Medical Devices & Instruments industry distribution chart, Strata Skin Sciences ranks #2 out of 335 companies for Median PS Value. This places Strata Skin Sciences in the top 1% of its industry — outperforming the majority of peers. The industry median Median PS Value is 0.71. Historically, Strata Skin Sciences' own Median PS Value has ranged from 0.04 to 0.85 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Median PS Value for a Medical Devices & Instruments company?
The median Median PS Value among Medical Devices & Instruments companies is 0.71, based on 335 companies in the industry. Companies in the top quartile (top 25%) have a Median PS Value significantly above this median, while those in the bottom quartile fall well below. However, Median PS Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Median PS Value mean?
A high Median PS Value can signal that a stock is expensive relative to its fundamentals. Median price-sales value is the stock value based on a company's 10-year median price-sales ratio, View historical data on Strata Skin Sciences and its competitors. For the Medical Devices & Instruments industry, the median Median PS Value is 0.71 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Strata Skin Sciences's current Median PS Value is €105.62, which is 23371% above median its own 10-year median of 0.45. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Strata Skin Sciences stock overvalued right now?
Strata Skin Sciences (FRA:E2O) has a current Median PS Value of €105.62. The stock's GF Value™ is €58.84, compared to a current price of €3.76 — trading 93.6% below its estimated fair value. The current Median PS Value is €105.62, which is 23371% above median its 10-year median of 0.45. Strata Skin Sciences' overall GF Score™ is 38/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Median PS Value calculated?
Median PS Value is calculated from a company's financial statements. For Strata Skin Sciences (FRA:E2O), the current Median PS Value is €105.62 as of Jun. 30, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Strata Skin Sciences (FRA:E2O) Overvalued in 2026?
Based on GuruFocus' analysis, Strata Skin Sciences stock appears to be undervalued.
The current stock price of €3.76 is trading 93.6% below its estimated GF Value™ of €58.84.
Key valuation signals for FRA:E2O:
Median PS Value: €105.62 (23371% above median its 10-year median of 0.45)
GF Value™: €58.84 vs. price of €3.76 (93.6% below fair value)
No single metric tells the full story. See the FRA:E2O stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Strata Skin Sciences Inc is a medical technology company engaged in developing and commercializing products for the treatment of dermatological disorders. Its primary products include the XTRAC excimer laser and VTRAC lamp systems utilized in the treatment of psoriasis, vitiligo, and various other skin conditions. Its operating segment includes Dermatology Recurring Procedures, which is the key revenue driver, and Dermatology Procedures Equipment. The Dermatology Recurring Procedures segment derives its revenues from the usage of its equipment by dermatologists to perform XTRAC procedures. Its Dermatology Procedures Equipment segment generates revenues from the sale of equipment, such as lasers and lamp products. Geographically, it derives a majority of revenue from the United States.
38GF Score
Get the complete analysis for FRA:E2O
Median PS Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:E2O has been successfully added to your 
